... are the areas of synthetic biology, single cell genomics, and cell and gene therapy which has become more and more important to large pharma.
https://www.google.com/url?rct=j&sa=t&url=https://biobuzz.io/in-conversation-bill-snider-partner-at-broadoak-capital-partners/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNEOTH1WBviVLGIE1umjvOsysG5qKg
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.